Regarding gene expression, cancer immune evasion-related genes were found up-regulated in the negative BL samples, such as CD274 (alias PD-L1), IDO1, LAG-3, CTLA4, and CD80 and CD86 genes, required for the activation of the inhibitory activity of CTLA4. The gene discussed is CD86; the disease is Burkitt lymphoma.